A company announces it has achieved 1,000 charge cycles in a battery cell the size of a business card, running at normal atmospheric pressure with no external clamp holding it together. The press release goes out. The stock moves. Investors update their models. But the critical question remains unanswered: what did that cell cost to make, and can you build ten million of them?
QuantumScape’s Osprey platform hits a real milestone. The company published data showing a QuantumScape solid state battery cell with a sulfide cathode completing 1,000 full cycles to 80% capacity at just 1 atmosphere of pressure. That matters because most sulfide cells in research labs require tens of atmospheres of external pressure to function, which means massive clamping systems that add weight, cost, and complexity. A cell that works at normal pressure is easier to package into a production vehicle. The technical achievement is genuine.
The question is whether it represents a capital allocation decision that creates durable value or an expensive demonstration that leads nowhere profitable.
What QuantumScape Actually Built
The tested cell is a 2-layer configuration with a 50 x 65 mm cathode area and a cathode loading of 5.5 mAh/cm², according to QuantumScape’s white paper. That works out to roughly 0.3 to 0.4 amp-hours of total capacity. For context, a production EV cell like QuantumScape’s current QSE-5 sample holds approximately 5 Ah. The Osprey test cell is roughly a tenth of that capacity.
The test ran at 1C charge and discharge rates (full charge in one hour), cycling from 0 to 100% state of charge at 30°C. The cell reached 1,000 cycles before dropping to 80% of its original capacity, which is the standard benchmark for battery degradation. QuantumScape also published fast-charging data showing the cell could charge from 10% to 80% in roughly fifteen minutes, with faster results at elevated operating temperatures; no detailed room-temperature fast-charge curve appeared in the white paper.
The Osprey platform is fully solid-state. It uses QuantumScape’s ceramic separator, a sulfide solid electrolyte in the cathode, and an anode-free design where lithium plates directly onto the separator during the first charge. The company manufactures the sulfide cathode using a proprietary dry process and positions Osprey as an “open platform,” meaning automakers can license QuantumScape’s cathode or bring their own.
The Capital Question Nobody Answered
QuantumScape did not publish a cost estimate for the Osprey cell. The white paper states that the process has been demonstrated at laboratory scale and that higher-throughput manufacturing processes remain in the development stage, with significant work remaining in process engineering. No production timeline was announced.
Compare that to the company’s existing QSE-5 platform, which ships as samples from the Eagle Line pilot production facility in San Jose. The QSE-5 cell uses a ceramic separator with a high-nickel NMC cathode and is a lithium-metal, anode-free design. QuantumScape reported roughly $9.8 million in Q3 customer billings, which suggests it is shipping enough QSE-5 cells to generate some revenue, albeit at pilot scale.
The company now has two development programs running in parallel: the QSE platform, which has paying customers and a clearer production path, and the Osprey platform, which has a white paper and no disclosed timeline. Both require capital. Both require engineering resources. Both compete for the same finite pool of supplier relationships, equipment vendors, and manufacturing expertise.
What the Industry Comparison Reveals
Samsung SDI is targeting mass production of sulfide all-solid-state cells in 2027. BYD plans small-batch sulfide production around 2027 and mass production toward the end of the decade. Toyota, after missing earlier targets, is now aiming for roughly 2027 to 2028. CATL has said true mass-market solid-state batteries are still years away, around 2030.
Every major battery manufacturer is working on sulfide solid-state cells. None of them have solved the cost problem. China’s FAW reported large-format sulfide cells cycling at elevated pressure (several megapascals, equivalent to tens of atmospheres) in 2024. QuantumScape’s achievement is running a much smaller cell at 1 atmosphere, but the white paper does not explain how to scale the manufacturing process or what the economics look like at production volumes.
The technical risk is real. The pressure required by conventional sulfide cells is substantial: tens of atmospheres applied across a large-format cell translates into thousands of kilograms of clamping force, requiring heavy and costly fixturing. Eliminating that pressure requirement is valuable, but only if the alternative manufacturing process is economically viable.
The Licensing Model as a Hedge
QuantumScape already licenses its technology to Volkswagen’s PowerCo. The Osprey platform extends that model to companies developing their own sulfide cathodes. QuantumScape has tested Osprey cells using cathodes developed by automotive customers, which suggests the licensing approach is intended to generate revenue even if QuantumScape’s proprietary sulfide cathode does not become the industry standard.
This is a capital-efficient strategy if the goal is to monetize intellectual property around the ceramic separator and anode-free design. Whether the company intends to establish itself as a vertically integrated cell manufacturer competing with CATL, LG Energy Solution, or Samsung SDI remains unclear.
The Missing Denominator
A battery cell that works in a lab is worth exactly zero dollars until someone can manufacture it profitably at scale. The Osprey white paper demonstrates that QuantumScape can build a small solid state battery cell that cycles 1,000 times at normal pressure. Whether the company can build ten million of them at a cost that makes economic sense in a $25,000 electric vehicle remains undemonstrated.
The QSE-5 platform has a clearer path to production: a pilot line is running and customers are paying for samples. The capital invested in QSE-5 is building toward a specific revenue model. The capital invested in Osprey is building toward a white paper and a technology demonstration.
That is not inherently wasteful. Early-stage R&D often looks like this. But at some point, a company has to decide whether it is a research lab publishing papers or a manufacturer shipping cells. QuantumScape is trying to be both, and the capital required to succeed at both simultaneously is substantial.
The real test is whether QuantumScape can turn that technical achievement into a manufacturing process that delivers cells to automakers at a cost that beats lithium iron phosphate. Until the company publishes a production cost estimate and a timeline, the Osprey announcement is a capabilities demonstration, not a capital allocation decision with a clear return.